PTCHF
PTCHF clinical trials: PureTech Health plc
Every trial on ClinicalTrials.gov where PureTech Health plc is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 9
- Trials linked
- 9
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
PTCHF on the catalyst calendar · PTCHF registry changes
- Primary completion Dec 12, 2024ActualPhase 1/Phase 2NCT04666688LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid TumorsPureTech · Metastatic CancerCompletedPTCHFLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2029Sponsor estimatePhase 3NCT07284602Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary...PureTech · Idiopathic Pulmonary Fibrosis (IPF)RecruitingPTCHFLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 17, 2025ActualPhase 1NCT06717100Study to Determine Potential for Drug-drug Interactions When Co-administering Deupirfenidone (LYT-100) and NintedanibPureTech · Drug InteractionsCompletedPTCHFLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 28, 2022ActualPhase 2NCT04652518LYT-100 in Post-acute COVID-19 Respiratory DiseasePureTech · Covid19TerminatedPTCHFLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2025ActualPhase 1NCT05829226A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk...PureTech · AML, Adult RecurrentCompletedPTCHFLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 1, 2022ActualPhase 1NCT07456800PK of Deupirfenidone Versus Pirfenidone in Older Healthy SubjectsPureTech · Pharmacokinetic AnalysisCompletedPTCHFLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 15, 2024ActualPhase 2NCT05321420LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)PureTech · Idiopathic Pulmonary FibrosisActive, not recruitingPTCHFLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 9, 2022ActualPhase 2NCT04243837LYT-100 in Patients With BCRLPureTech · Breast Cancer Related LymphoedemaTerminatedPTCHFLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 18, 2023ActualPhase 1/Phase 2NCT05129865LYT-300 in Healthy VolunteersPureTech · Healthy VolunteersCompletedPTCHFLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 9 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner